Gene "ABCC6"
Found 7 records
Gene information
Gene symbol:
ABCC6
See related:
Ensembl: ENSG00000091262, Gene ID: 368
Additive variants :
Detected
Genetic interaction partners
Confidence      Stringent (ε>0.16 or ε<-0.12)      Intermediate (-0.16≤ε≤-0.08 or 0.08≤ε≤0.16)      Lenient (|ε|<0.08)
Positive interactions
  • SIN3A 
  • RPS27 
  • SLC25A26 
  • DLAT 
  • GALT 
  • RPS11 
  • RPS4X 
  • RPS16 
  • XPC 
  • IDH3B 
  • BUD31 
  • PDXK 
  • IMMP2L 
  • PCSK9 
  • SUCO 
  • ACAA1 
  • ASF1A 
  • PPIL6 
  • LEO1 
  • PEX10 
  • IDH3A 
  • INPP5E 
  • KATNA1 
  • VPS35 
  • WDR48 
  • PPP2R5C 
  • GPD1L 
  • SCAP 
  • POMT2 
  • MIOS 
  • DMXL1 
  • DDI2 
  • VPS26B 
  • KIFC2 
  • OSGEPL1 
  • PEX1 
  • EEF1G 
  • STRIP2 
  • EGR3 
  • TBK1 
  • SLC47A2 
  • RPS28 
  • RPS6 
  • D2HGDH 
  • ASZ1 
  • EEF1G 
  • RAB5B 
  • RPSA 
  • FAU 
  • OGFOD1 
  • EMC3 
  • CSNK2A2 
  • CRLS1 
  • CERK 
  • AP1G1 
  • HAAO 
  • PRDX1 
  • CCNA2 
  • ALPL 
  • ARHGAP11A 
  • ATP1A1 
  • APRT 
  • PCSK9 
  • ABHD5 
  • FAF1 
  • OTUD6A 
  • AP3S2 
  • NIT1 
Negative interactions
  • ATAD2 
  • SAC3D1 
  • SMARCB1 
  • DBT 
  • MLH1 
  • ADA 
  • KMO 
  • ATP23 
  • USP17L30 
  • TREH 
  • NF1 
  • DPH5 
  • RANGRF 
  • USP41 
  • DDX31 
  • PPAT 
  • DOHH 
  • MOK 
  • HGH1 
  • TBL1XR1 
  • MAST2 
  • ACSF2 
  • RAD52 
  • WIPI2 
  • DYNC2H1 
  • GOLPH3L 
  • SDHAF2 
  • ASNA1 
  • ABCC5 
  • PYGM 
  • PPTC7 
  • DRG1 
  • CTSA 
  • MSH3 
  • LSM1 
  • LIPT1 
  • UBL5 
  • CHCHD2 
  • TESC 
  • PRKG2 
  • AGL 
  • AIRE 
  • REXO1 
  • ADI1 
  • ALG8 
  • AMD1 
  • ELOVL1 
  • OGG1 
  • SIRT2 
  • UBE4B 
  • GGPS1 
  • ASH1L 
  • TMED9 
  • PPP6R3 
  • SLC30A6 
  • PGGHG 
  • PPEF2 
  • MAD2L1 
  • SLC25A4 
  • IPO8 
  • NRDC 
  • ALDH1L2 
  • SMS 
  • TSSK3 
  • SLC25A44 
  • RPL14 
  • ALG12 
  • ITPA 
  • NIF3L1 
  • SLC35B1 
  • BECN2 
  • FBP1 
  • RPS9 
  • ISY1-RAB43 
  • XPOT 
  • WDR17 
  • MUS81 
  • RPS23 
  • MDH2 
  • PAN3 
  • TREH 
  • EDF1 
  • GDA 
Modifier statisitcs
Record:
Disorder:
Vriant:
Reference:
Effect type:
Expressivity(7)  
Modifier effect:
Risk factor(7)  
Details:
  • Variant 1:
    Gene:
    Genomic location:
    dbSNP ID:
    Alias:
    ABCC6:p.R621C
    Target disease:
    Effect type:
    Expressivity 
    Modifier effect:
    Risk factor 
    Evidence:
    From review article 
    Effect:
    ABCC6 mutations on a single allele might determine a mild PXE phenotype
    Reference:
    Title:
    New insights into the pathogenesis of pseudoxanthoma elasticum and related soft tissue calcification disorders by identifying genetic interactions and modifiers.
    Species studied:
    Human
    Abstract:
    Screening of the adenosine triphosphate binding cassette transporter protein subfamily C member 6 gene (ABCC6) in pseudoxanthoma elasticum (PXE) revealed a mutation detection rate of approximately 87%. Although 25% of the unidentified disease alleles underlie deletions/insertions, there remain several PXE patients with no clear genotype. The recent identification of PXE-related diseases and the high intra-familiar and inter-individual clinical variability of PXE led to the assumption that secondary genetic co-factors exist. Here, we summarize current knowledge of the genetics underlying PXE and PXE-related disorders based on human and animal studies. Furthermore, we discuss the role of genetic interactions and modifier genes in PXE and PXE-related diseases characterized by soft tissue calcification.
  • Variant 2:
    Gene:
    Genomic location:
    dbSNP ID:
    Alias:
    ABCC6:p.R621C
    Target disease:
    Effect type:
    Expressivity 
    Modifier effect:
    Risk factor 
    Evidence:
    From review article 
    Effect:
    ABCC6 mutations on a single allele might determine a mild PXE phenotype
    Reference:
    Title:
    New insights into the pathogenesis of pseudoxanthoma elasticum and related soft tissue calcification disorders by identifying genetic interactions and modifiers.
    Species studied:
    Human
    Abstract:
    Screening of the adenosine triphosphate binding cassette transporter protein subfamily C member 6 gene (ABCC6) in pseudoxanthoma elasticum (PXE) revealed a mutation detection rate of approximately 87%. Although 25% of the unidentified disease alleles underlie deletions/insertions, there remain several PXE patients with no clear genotype. The recent identification of PXE-related diseases and the high intra-familiar and inter-individual clinical variability of PXE led to the assumption that secondary genetic co-factors exist. Here, we summarize current knowledge of the genetics underlying PXE and PXE-related disorders based on human and animal studies. Furthermore, we discuss the role of genetic interactions and modifier genes in PXE and PXE-related diseases characterized by soft tissue calcification.
  • Gene:
    Genomic location:
    chr16:16251599
    dbSNP ID:
    Target disease:
    Effect type:
    Expressivity 
    Modifier effect:
    Risk factor 
    Evidence:
    From review article 
    Effect:
    ABCC6 mutations on a single allele might determine a mild PXE phenotype
    Reference:
    Title:
    New insights into the pathogenesis of pseudoxanthoma elasticum and related soft tissue calcification disorders by identifying genetic interactions and modifiers.
    Species studied:
    Human
    Abstract:
    Screening of the adenosine triphosphate binding cassette transporter protein subfamily C member 6 gene (ABCC6) in pseudoxanthoma elasticum (PXE) revealed a mutation detection rate of approximately 87%. Although 25% of the unidentified disease alleles underlie deletions/insertions, there remain several PXE patients with no clear genotype. The recent identification of PXE-related diseases and the high intra-familiar and inter-individual clinical variability of PXE led to the assumption that secondary genetic co-factors exist. Here, we summarize current knowledge of the genetics underlying PXE and PXE-related disorders based on human and animal studies. Furthermore, we discuss the role of genetic interactions and modifier genes in PXE and PXE-related diseases characterized by soft tissue calcification.
  • Variant 4:
    Gene:
    Genomic location:
    dbSNP ID:
    Target disease:
    Effect type:
    Expressivity 
    Modifier effect:
    Risk factor 
    Evidence:
    From review article 
    Effect:
    ABCC6 mutations on a single allele might determine a mild PXE phenotype
    Reference:
    Title:
    New insights into the pathogenesis of pseudoxanthoma elasticum and related soft tissue calcification disorders by identifying genetic interactions and modifiers.
    Species studied:
    Human
    Abstract:
    Screening of the adenosine triphosphate binding cassette transporter protein subfamily C member 6 gene (ABCC6) in pseudoxanthoma elasticum (PXE) revealed a mutation detection rate of approximately 87%. Although 25% of the unidentified disease alleles underlie deletions/insertions, there remain several PXE patients with no clear genotype. The recent identification of PXE-related diseases and the high intra-familiar and inter-individual clinical variability of PXE led to the assumption that secondary genetic co-factors exist. Here, we summarize current knowledge of the genetics underlying PXE and PXE-related disorders based on human and animal studies. Furthermore, we discuss the role of genetic interactions and modifier genes in PXE and PXE-related diseases characterized by soft tissue calcification.
  • Gene:
    Genomic location:
    chr16:16256935
    dbSNP ID:
    Target disease:
    Effect type:
    Expressivity 
    Modifier effect:
    Risk factor 
    Evidence:
    From review article 
    Effect:
    ABCC6 mutations on a single allele might determine a mild PXE phenotype
    Reference:
    Title:
    New insights into the pathogenesis of pseudoxanthoma elasticum and related soft tissue calcification disorders by identifying genetic interactions and modifiers.
    Species studied:
    Human
    Abstract:
    Screening of the adenosine triphosphate binding cassette transporter protein subfamily C member 6 gene (ABCC6) in pseudoxanthoma elasticum (PXE) revealed a mutation detection rate of approximately 87%. Although 25% of the unidentified disease alleles underlie deletions/insertions, there remain several PXE patients with no clear genotype. The recent identification of PXE-related diseases and the high intra-familiar and inter-individual clinical variability of PXE led to the assumption that secondary genetic co-factors exist. Here, we summarize current knowledge of the genetics underlying PXE and PXE-related disorders based on human and animal studies. Furthermore, we discuss the role of genetic interactions and modifier genes in PXE and PXE-related diseases characterized by soft tissue calcification.
  • Gene:
    Genomic location:
    dbSNP ID:
    Target disease:
    Effect type:
    Expressivity 
    Modifier effect:
    Risk factor 
    Evidence:
    From review article 
    Effect:
    ABCC6 mutations on a single allele might determine a mild PXE phenotype
    Reference:
    Title:
    New insights into the pathogenesis of pseudoxanthoma elasticum and related soft tissue calcification disorders by identifying genetic interactions and modifiers.
    Species studied:
    Human
    Abstract:
    Screening of the adenosine triphosphate binding cassette transporter protein subfamily C member 6 gene (ABCC6) in pseudoxanthoma elasticum (PXE) revealed a mutation detection rate of approximately 87%. Although 25% of the unidentified disease alleles underlie deletions/insertions, there remain several PXE patients with no clear genotype. The recent identification of PXE-related diseases and the high intra-familiar and inter-individual clinical variability of PXE led to the assumption that secondary genetic co-factors exist. Here, we summarize current knowledge of the genetics underlying PXE and PXE-related disorders based on human and animal studies. Furthermore, we discuss the role of genetic interactions and modifier genes in PXE and PXE-related diseases characterized by soft tissue calcification.
  • Variant 7:
    Gene:
    Genomic location:
    dbSNP ID:
    Target disease:
    Effect type:
    Expressivity 
    Modifier effect:
    Risk factor 
    Evidence:
    From review article 
    Effect:
    ABCC6 mutations on a single allele might determine a mild PXE phenotype
    Reference:
    Title:
    New insights into the pathogenesis of pseudoxanthoma elasticum and related soft tissue calcification disorders by identifying genetic interactions and modifiers.
    Species studied:
    Human
    Abstract:
    Screening of the adenosine triphosphate binding cassette transporter protein subfamily C member 6 gene (ABCC6) in pseudoxanthoma elasticum (PXE) revealed a mutation detection rate of approximately 87%. Although 25% of the unidentified disease alleles underlie deletions/insertions, there remain several PXE patients with no clear genotype. The recent identification of PXE-related diseases and the high intra-familiar and inter-individual clinical variability of PXE led to the assumption that secondary genetic co-factors exist. Here, we summarize current knowledge of the genetics underlying PXE and PXE-related disorders based on human and animal studies. Furthermore, we discuss the role of genetic interactions and modifier genes in PXE and PXE-related diseases characterized by soft tissue calcification.